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Introduction 
Diabetes mellitusa metabolic disorder characterized by 
an inappropriate hyperglycemia caused by a relative or 
absolute deficiency of insulin or by a resistance to the 
action of insulin at the cellular level is found in all parts 
of  the  world.
1  If  diabetes  is  not  being  controlled 
effectively, the  patient  would have  advanced  risks  of 
developing complications, like hypoglycemia, ketoaci-
dosis, and nonketotic hyper-osmolar coma. The longer 
term  complications  might  be  cardiovascular  disease, 
nerve damage, chronic kidney failure, retinal damage, 
and scanty healing of wounds, followed by gangrene on 
the  feet  leading  to  amputation.
2-5  It  has  been  well 
recognized  that  these  complications  bring  about 
significant  morbidity  and  mortality  statistics  world-
wide, which is affecting negatively the quality of life in 
patients with diabetes.  
From the patient’s perspective, the major objective is to 
design a regimen that will improve the progression of 
the disease complications. It has been considered very 
acceptable to include herbal or botanical extracts as a 
part of medical treatment. Although, herbs for diabetes 
treatment are not new and the plants and plant extracts 
since  ancient  times  were  used  to  combat  diabetes, 
administration  of  herbal  remedies  in  the  case  of 
diabetes diseases should certainly not be discounted.
1,6-9 
Accordingly,  the  present  study  was  conducted  to 
analyze  one  of  the  herbs,  Fumaria  parviflora,  being 
employed  traditionally  by  native  people  in  the  treat-
ment of diabetes with an inadequate knowledge base. 
Fumaria  parviflora  Lam.  (Fumariaceae)  an  annual 
herbaceous  plant  that  grows  in  wide  variety  parts  of 
Iran, Pakistan and Turkey that has been reported to be 
used  traditionally  in  dermatological  diseases,  in 
stimulation of liver function and gall bladder and also 
as  antiscabies,  antiscorbite,  antibronchite,  diuretic, 
expectorant,  antipyretic,  diaphoretic,  appetizer  and 
laxative.
10  Studies  dealing  with  the  bioactivity  and 
potential  health  benefits  of  F.  parviflora  in  different 
aspects have been previously reported.  The antinoici-
ceptive and histopathological effects of the percolated 
and  soxhlet  methanol  extract  of  F.  parviflora  in 
formalin  test  was  determined,  especially  at  the  late 
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Purpose: Fumaria parviflora Lam (Fumariaceae) has been used in traditional medicine 
in the treatment of several diseases such as diabetes. The present work was designed to 
evaluate  the  hypoglycaemic  effects  of  methanolic  extract  (ME)  of  F.  parviflora  in 
normal and streptozotocin-induced diabetic rats. Methods: The rats used were allocated 
in six (I, II, III, IV, V and VI) experimental groups (n=5). Group I rats served as ‘normal 
control’ animals received distilled water and group II rats served as ‘diabetic control’ 
animals. Diabetes mellitus was induced in groups II, V and VI rats by intraperitoneal 
single injection of streptozotocin (STZ, 55 mg kg-1). Group V and VI rats were addi-
tionally treated with ME (150 mg kg-1 day-1 and 250 mg kg-1 day-1, i.p. respectively) 
24 hour post STZ injection, for seven consecutive days. Groups III and IV rats received 
only ME 150 mg kg-1 day-1 and 250 mg kg-1 day-1, i.p. respectively for seven days. 
The levels of blood glucose were determined using a Glucometer. Results: Administra-
tion of F. parviflora extract showed a potent glucose lowering effect only on streptozo-
tocin (STZ) induced diabetic rats below 100 mg/dl (P<0.001). However, no significant 
differences in the blood glucose levels were recorded between diabetic rats received 125 
or 250 mg/kg of plant extracts. Conclusion: The findings of the study indicated that F. 
parviflora  has  significant  hypoglycemic  effect  on  STZ-induced  diabetic  rats  with  no 
effects on blood glucose levels of normal rats.  
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phase  and  hot-plate  test  in  mice  and  rats.
11  Various 
species of Fumaria have been studied by Orhan et al. 
which showed anticholinesterase activity for extracts of 
the  aerial  parts  of  F.  parviflora.
12  Moreover,  phyto-
chemical  analyses  of  some  plants  of  genus  Fumaria, 
including  F.  parviflora  has  indicated  presence  of 
isoquinoline  alkaloids.
13-17  Elsewhere,  the  antipyretic 
activity  of  the  hexane,  chloroform  and  water-soluble 
extracts  of  F.  parviflorain  rabbits  was  verified.
18 
Akhtar et al. in 1984 published a paper in which they 
examined the blood glucose levels of the normal and 
alloxan-diabetic male albino rabbits after oral adminis-
tration of various doses of the powdered F. parviflora 
and  concluded  that  the  plant  contained  some  hypo-
glycaemic  properties.
19  However,  firm  recommenda-
tions  for  general  use  of  any  herbal  remedies  needs 
detailed  documentations  of  the  glucose  or  insulin 
lowering effects of the plants in diabetes. Herein, we 
have evaluated the effect of the methanol extract of F. 
parvifloraon  blood  glucose  level  in  normal  and 
streptozotocin STZ-induced diabetic rats. 
 
Materials and Methods 
Plant Material 
The  aerial  parts  of  Fumaria  parviflora  Lam  were 
collected during June–July from Aharin East Azerbay-
jan province in Iran. A voucher specimen of the plant 
representing  this  collection  has  been  retained  in  the 
herbarium of the Faculty of Pharmacy, Tabriz Universi-
ty of Medical Science, Tabriz, Iran. 
 
Preparation of Plant Extract 
Aerial parts of plants (200 g) were air dried, powdered 
and  extracted  with  maceration  in  chloroform  and 
methanol (4×1L) consecutively and then evaporated in 
vacuo  to  afford  chloroform  and  methanol  extracts 
(ME).  Since,  in  our  preliminary  study  chloroform 
extract  showed  no  effect  on  blood  glucose  level  in 
normal  and  diabetic  rats,  the  assessment  of  hypogly-
cemic activity of the plant set out on ME. Without any 
further  purification,  the  crude  methanol  extract  was 
refrigerated  and  subsequently  used  in  this  study. 
Aliquot portions of the crude ME residue was weighed 
and dissolved in distilled water for use on each day of 
our experiments. 
 
 Animals 
Thirty  male  Wistar  albino  rats  weighing  200-220  g 
were obtained from animal facility of pasture institute 
of Iran and were used in this survey. The animals were 
housed  in  stainless  steel  cages  under  controlled 
environmental conditions (temperature 25±5 ºC, with a 
light/dark cycle of 12 hours). The cage contained 5 rats 
and each rat had a tag number. Rats were allowed free 
access  to  concentrated  animal  food  and  water  every 
day. Housing and caring conditions for the animals and 
the  study  protocols  for  the  animal  experiments  were 
carried  out  in  accordance  with  the  internationally 
accepted  principles  and  the  national  laws  concerning 
the care and the use of laboratory animals. 
 
Induction of Experimental Diabetes 
Diabetes  type  2  was  induced  with  a  single  intra-
peritoneal  injection  of  a  freshly  prepared  solution  of 
streptozotocin  (STZ)  (55mg/kg),  dissolved  in  cold 
citrate buffer (0.1M, pH 4.5), immediately before use 
due to the instability of STZ in aqueous media. 
 
Measurement of Blood Glucose Levels 
The  blood  was  drawn  from  the  tail  and  basal  blood 
glucose  levels  were  determined  using  an  automated 
blood  glucose  analyzer  (Glucometer  One  touch, 
Germany) prior to STZ injection and every 24h after 
STZ injection in groups II, V and VI and 1h after ME 
i.p. injection.  Rats  with blood  glucose  concentrations 
above 250 mg/dl were declared diabetic. 
 
Experimental Designand Animal Grouping 
The  experimental  animals  were  allowed  2-week 
acclimatization  to  laboratory  environment  and  they 
were subsequently divided into 6 groups comprising of 
5  animals  in  each  group  as  follows:  Group  I,  was 
considered  as  normal  rats  (distilled  water-treated, 
Control),  group  II,  diabetic  control  (STZ-treated), 
group  III,  extract-treated  (normal  +  125  mg/kg  body 
weight/day  of  ME)  rats,  group  IV  extract-treated 
(normal  +  250  mg/kg/day  of  ME)  rats,  group  V, 
diabetic +  125  mg/kg/day  of ME  rats  and  group  VI, 
diabetic + 250 mg/kg/day of ME rats. In groups V and 
VI  administration  of  ME  commenced  24h  after 
injection of STZ and continued for the next 7 days. 
 
Statistical Analysis 
All the data are expressed as Mean ± S.E.M (standard 
error of means) and a probability level of P < 0.05 was 
taken to be statistically significant in the analyses. 
 
Results 
Blood glucose levels in different groups of control and 
experimental pre and after intra-peritoneal administra-
tion  of  STZ  and  plant  extract  were  represented  in 
Figure 1. In the control diabetic rats, blood glucose was 
reached maximum to its  peak of about 346.88  mg/dl 
and remained high up to 192h during the experiment. 
Whereas,  control  group  of  normal  rats,  group  I,  did 
show no changes in mean±SEM blood glucose levels. 
Additionally, administration of ME in groups III  and 
IV  showed  no  effect  on  blood  glucose  levels  when 
compared with normal rats. The findings of the study 
verified in diabetic treated rats with different concen-
trations of plant methanol extract (125 mg/kg and 250 
mg/kg)  levels  of  blood  glucose  were  markedly 
controlled below 100 mg/dl at the end of the experi-
ments. However, no significant differences in the blood 
glucose  levels  were  recorded  between  diabetic  rats 
received  125  or  250  mg/kg/day  of  plant  extract  and 
they both decreased the blood glucose levels, evidently.  
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Figure 1. Effect of Methanol extract of F. parviflora on blood 
glucose levels in normal and diabetic rats. Data were given as 
mean ± SEM for five animals in each group. 
*  Groups  [I:  Normal  controls,  II:  Diabetic  controls,  III:  Normal  +  125 
mg/kg/day of extract, IV: Normal + 250 mg/kg/day of extract, V: Diabetic 
+ 125 mg/kg/day of extract, VI: Diabetic + 250 mg/kg/day of extract]. 
 
Discussion 
The  use  of  medicinal  plants  in  treatment  of  diseases 
have  been  an  important  part  of  medicinal  therapy  as 
observed  for  thousands  of  years  contributing  to 
scientific search of safer phytotherapeutic products, in 
this  regard.  Ever-increasing  diabetes  mellitus  draw 
scores of researchers' attention to this phenomenon as a 
serious  threat  to  mankind  health  in  all  parts  of  the 
world. In spite of the traditional use of botanicals in 
treatment  of  diabetes,  paucity  of  definitive  data  on 
efficacy of these herbal remedies still deals a challenge 
in this field. In view of the fact that the diabetogenic 
effect of STZ is the direct consequence of irreversible 
damage  to  the  pancreatic  beta  cells,  resulting  in 
degradation and loss of insulin secretion, STZ induced 
hyperglycemia  has  been  recognized  as  a  convenient 
experimental model to evaluate the activity of hypogly-
cemic  agents.
20,21  Intra-peritoneal  administration  of 
STZ (55 mg/kg) effectively induced diabetes in normal 
rats  as  reflected  by  hyperglycaemia  when  compared 
with  normal  rats.
22-24  In  our  present  study  we  have 
assessed the hypoglycemic activity of F. parviflora on 
normal and STZ induced diabetic rats. 
The results revealed that F. parviflorahad no effect on 
the blood glucose level in normal rats (group III and 
IV). Therefore, it is possible to propose that in addition 
to insulin-like activity of the ME other mechanism such 
as alteration in the insulin-resistance pathway may be 
involved by ME. Hence, this pathway has no role in the 
normal animals, the extract was not able to change the 
blood glucose level in groups III and IV. Additionally, 
it can be suggested that insulin–resistance pathway in 
the peripheral tissues, possibly is superior to its insulin-
like activity. However, this theory should be confirmed 
with further in vivo and in vitro studies.  
Considering  the  results,  administration  of  the  plant 
extract  exhibited  a  superb  blood  glucose  lowering 
activity in diabetic rats providing an evidence for the 
merit of the traditional use of F. parviflora among the 
nations. In all probability, F. parviflora do appear to be 
helpful  in  diabetic  patients  as  claimed  and  do  have 
potential anti-diabetic effects in a rat model system of 
diabetes mellitus since the results are as striking in this 
study. 
 
Conclusion 
The present investigation is an evidence for the anti-
diabetic  activity  of  F.  parviflora  in  STZ  induced 
diabetic  rats.  The  authors  believe  that  F.  parviflora 
could  be  considered  as  an  excellent  candidate  for 
further  studies  on  verifying  the  mechanisms  of 
hypoglycemic activity, as well as for the isolation and 
identification  of  the  foremost  hypoglycemic  phyto-
chemical  responsible  for  anti-diabetic  activity  of  the 
plant. Besides, further comprehensive pharmacological 
surveys, involving experimental chronic studies, will be 
of value to assess the possible toxicological effects of 
this anti-diabetic plant. 
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